Recent Advances in Lipid Nanoparticles and Their Safety Concerns for mRNA Delivery
Vaccines · 08.10.2024 · 12 (10) · 1148
DOI: 10.3390/vaccines12101148 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Vaccines, online erschienen am 08.10.2024. Verfasst von Jialiang Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Meinig School of Biomedical Engineering, Cornell University, Ithaca, NY 14853, USA. Die Arbeit wurde bisher 257-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases, National Cancer Institute.
Abstract (Originalsprache)
Introduction: The advent of lipid nanoparticles (LNPs) as a delivery platform for mRNA therapeutics has revolutionized the biomedical field, particularly in treating infectious diseases, cancer, genetic disorders, and metabolic diseases. Recent Advances in Therapeutic LNPs: LNPs, composed of ionizable lipids, phospholipids, cholesterol, and polyethylene glycol (PEG) lipids, facilitate efficient cellular uptake and cytosolic release of mRNA while mitigating degradation by nucleases. However, as synthetic entities, LNPs face challenges that alter their therapeutic efficacy and safety concerns. Toxicity/Reactogenicity/Immunogenicity: This review provides a comprehensive overview of the latest advancements in LNP research, focusing on preclinical safety assessments encompassing toxicity, reactogenicity, and immunogenicity. Summary and Outlook: Additionally, it outlines potential strategies for addressing these challenges and offers insights into future research directions for enhancing the application of LNPs in mRNA therapeutics.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Meinig School of Biomedical Engineering, Cornell University, Ithaca, NY 14853, USA.
- Smith School of Chemical and Biomolecular Engineering, Cornell University, Ithaca, NY 14853, USA.
- Department of Materials Science and Engineering, Cornell University, Ithaca, NY 14853, USA.
- Department of Biological and Environmental Engineering, Cornell University, Ithaca, NY 14853, USA.
ORCID-Profile: Kellie Chong
Förderung
- NIAID NIH HHS
- National Institute of Allergy and Infectious Diseases
- National Cancer Institute
- Cornell University
Zitieren
APA
Wang, J., Ding, Y., Chong, K., Cui, M., Cao, Z., Tang, C., Tian, Z., Hu, Y., Zhao, Y., & Jiang, S. (2024). Recent Advances in Lipid Nanoparticles and Their Safety Concerns for mRNA Delivery. Vaccines, 12(10), 1148. https://doi.org/10.3390/vaccines12101148
Vancouver
Wang J, Ding Y, Chong K, Cui M, Cao Z, Tang C, et al. Recent Advances in Lipid Nanoparticles and Their Safety Concerns for mRNA Delivery. Vaccines. 2024;12(10):1148. doi:10.3390/vaccines12101148
BibTeX
@article{Wang2024,
author = {Wang, Jialiang and Ding, Yaopeng and Chong, Kellie and Cui, Meng and Cao, Zeyu and Tang, Chenjue and Tian, Zhen and Hu, Yuping and Zhao, Yu and Jiang, Shaoyi},
title = {Recent Advances in Lipid Nanoparticles and Their Safety Concerns for mRNA Delivery},
journal = {Vaccines},
year = {2024},
volume = {12},
number = {10},
pages = {1148},
doi = {10.3390/vaccines12101148}
}
EUVIMED